Compare RSVR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RSVR | YDES |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.8M | 543.0M |
| IPO Year | 2020 | 2024 |
| Metric | RSVR | YDES |
|---|---|---|
| Price | $9.27 | $3.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | 49.7K | ★ 356.2K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.33 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $175,664,491.00 | N/A |
| Revenue This Year | $10.95 | N/A |
| Revenue Next Year | $4.16 | N/A |
| P/E Ratio | $71.92 | ★ N/A |
| Revenue Growth | ★ 10.69 | N/A |
| 52 Week Low | $7.07 | $1.70 |
| 52 Week High | $13.39 | $22.00 |
| Indicator | RSVR | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 54.41 |
| Support Level | $7.31 | $2.99 |
| Resistance Level | $10.34 | $5.15 |
| Average True Range (ATR) | 0.34 | 0.78 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 55.80 | 48.31 |
Reservoir Media Inc is an independent music company. The company operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the U.S. Music Publishing segment engaged in the acquisition of interests in music catalogs to earn royalties and signing songwriters to agreements of future delivery of songs. The Recorded Music segment involve the acquisition of sound recording catalogs and the discovery and development of recording artists and the marketing, distribution, sale and licensing of the music catalog.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.